337 related articles for article (PubMed ID: 16856434)
1. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
3. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
6. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
7. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Alsaran K; Grisaru S; Stephens D; Arbus G
Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F; Ahmad TM; Anwar S
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[TBL] [Abstract][Full Text] [Related]
9. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
Ladapo TA; Esezobor CI; Lesi FE
Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P; Jesdapatarakul S
J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
14. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
Podracká L; Böör A; Sasinka M
Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
[TBL] [Abstract][Full Text] [Related]
15. Steroid resistant nephrotic syndrome: role of histopathology.
Gulati S; Sengupta D; Sharma RK; Sharma A; Gupta RK; Singh U; Gupta A
Indian Pediatr; 2006 Jan; 43(1):55-60. PubMed ID: 16465008
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
Prasher PK; Varma PP; Baliga KV
J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
McQuarrie EP; Stirling CM; Geddes CC
Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT; Yang LY
J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
[TBL] [Abstract][Full Text] [Related]
20. Pefloxacin in steroid dependent and resistant idiopathic nephrotic syndrome.
Sharma RK; Sahu KM; Gulati S; Gupta A
J Nephrol; 2000; 13(4):271-4. PubMed ID: 10946806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
